Psyadon Pharmaceuticals (United States)
- Research works
- 36 ▼ 15% vs 2013–17
- Citations
- 554 15.2 per fractional work
- Top-10% rate
- 37.7% record average 16.5%
- Open access
- 11% world 28%
Not ranked overall: Psyadon Pharmaceuticals (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Which keywords describe research at Psyadon Pharmaceuticals (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Immunotherapy, Tumor Microenvironment, Therapeutic Targets, Regulation, Cancer Therapy, Antiretroviral Therapy, Cancer Progression and Enzyme Regulation.
- DNA Damage
- Inflammation
- Cancer
- Synthesis
- Drug Discovery
- Arginine Deprivation
- DNA Structure
- Nanoparticles
- Integrase Inhibitors
- p53
- MDM2
- Tumor Targeting
- Chemotherapy
- Drug Resistance
- RNA methylation
- Enzyme Regulation
- Cancer Progression
- Regulation
- Tumor Microenvironment
- Immunotherapy
- Therapeutic Targets
- Antiretroviral Therapy
- Cancer Therapy
- Nucleotide Metabolism
- m6A-seq
- Apoptosis
- Gene Therapy
- Cell Cycle
- Tumor Suppression
- HIV Infection
- Medicinal Chemistry
- Genomic Stability
- G-Quadruplexes
- Bacterial Therapy
- Oxidative Stress
- Biological Evaluation
- Epidemiology
- Treatment
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 38 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 38 words, with their numbers
- Immunotherapy3▲ 14×8 topics
- Tumor Microenvironment3▲ 25×6 topics
- Therapeutic Targets3▲ 32×4 topics
- Regulation3▲ 12×2 topics
- Antiretroviral Therapy2▲ 30×2 topics
- Cancer Progression2▲ 30×2 topics
- Cancer Therapy2▲ 11×4 topics
- Enzyme Regulation2▲ 140×1 topic
- Nucleotide Metabolism2▲ 194×1 topic
- RNA methylation2▲ 85×1 topic
- m6A-seq2▲ 85×1 topic
- Drug Resistance2▲ 21×3 topics
- Apoptosis2▲ 16×3 topics
- Chemotherapy2▲ 8.2×7 topics
- Gene Therapy2▲ 21×2 topics
- Tumor Targeting2▲ 43×3 topics
- Cell Cycle2▲ 96×2 topics
- MDM22▲ 125×1 topic
- Tumor Suppression2▲ 48×2 topics
- p532▲ 125×1 topic
- HIV Infection2▲ 43×1 topic
- Integrase Inhibitors2▲ 128×1 topic
- Medicinal Chemistry2▲ 14×7 topics
- Nanoparticles2▲ 4.0×4 topics
- Genomic Stability2▲ 52×2 topics
- DNA Structure2▲ 68×1 topic
- G-Quadruplexes2▲ 68×1 topic
- Arginine Deprivation1▲ 87×1 topic
- Bacterial Therapy1▲ 87×1 topic
- Drug Discovery1▲ 8.7×4 topics
- Oxidative Stress1▲ 1.97×6 topics
- Synthesis1▲ 5.7×6 topics
- Biological Evaluation1▲ 24×4 topics
- Cancer1▲ 2.1×7 topics
- Epidemiology1▼ 0.74×6 topics
- Inflammation1▲ 1.30×3 topics
- Treatment1▲ 2.4×3 topics
- DNA Damage1▲ 21×2 topics
Which research topics does Psyadon Pharmaceuticals (United States) publish most on?
By volume in 2022–2025: Xenotransplantation and immune response, Diabetes and associated disorders, Emergency and Acute Care Studies and Transplantation: Methods and Outcomes.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Xenotransplantation and immune response Surgery 0 works
- 2 Diabetes and associated disorders Genetics 0 works
- 3 Emergency and Acute Care Studies Emergency Medicine 0 works
- 4 Transplantation: Methods and Outcomes Surgery 0 works
- 5 Healthcare Policy and Management Economics and Econometrics 0 works
- 6 Patient Safety and Medication Errors Emergency Medical Services 0 works
- 7 Organ Transplantation Techniques and Outcomes Surgery 0 works
- 8 Renal Transplantation Outcomes and Treatments Transplantation 0 works
- 9 Pancreatic function and diabetes Surgery 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Psyadon Pharmaceuticals (United States)'s research output changed?
Output in 2018–2022 was 15% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Germantown
- American College of Veterinary Surgeons
- Avalon Pharma (United States)
- Intelligent Fusion Technology (United States)
- Senseonics (United States)
- Earth Networks (United States)
- Herrick Technology Laboratories (United States)
- Zalgen (United States)
- C-Motion (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.